(2026). Bridging the gap in OA therapeutics: Bioengineered strategies to target osteoclast–chondrocyte crosstalk. Bioengineering & Translational Medicine.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Bridging the Gap in OA Therapeutics: Bioengineered Strategies to Target Osteoclast–chondrocyte Crosstalk."
Bioengineering & Translational Medicine 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Bridging the Gap in OA Therapeutics: Bioengineered Strategies to Target Osteoclast–chondrocyte Crosstalk."
Bioengineering & Translational Medicine, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.